GL1X · GenesisL1 explorer

Research workbench

HIV protease with scripps ab-3 inhibitor

Analyse HIV protease with scripps ab-3 inhibitor in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
1ZPA
Type
protein
Length
99 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Pol polyprotein
EC
3.4.23.16
UniProt
P03368
Ligands
A83
Pockets
2 · best druggability 0.47

Structure

x-ray diffraction · 1 distinct chain · 6% helix, 48% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
APol polyprotein (EC 3.4.23.16)protein996% helix, 48% strandP03368

Ligands and binding sites

  • A83 · Tert-butyl 4-[({[1-((1S,2R)-1-benzyl-2-hydroxy-3-{isobutyl[(4-methoxyphenyl)sulfonyl]amino}propyl)-1H-1,2,3-triazol-4-yl]methyl}amino)carbonyl]benzylcarbamate · ligand · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

2 pockets found on a 1 Å grid, 0 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
11520.470.7619empty
2500.270.7417empty

Compared structures

  • 1ZPA · HIV Protease with Scripps AB-3 Inhibitor · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.